CLPT

$10.26+5.66%visit website

ClearPoint Neuro, Inc.

Market Cap

$329M

Live price × SEC shares (Oct 21, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

1.33

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

7.2

TTM to Sep 2026 · revenue

P/B

12.1

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Sep 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	10,410	12,128	10,880	12,075	45,493
Cost of revenue	4,006	4,372	4,170	5,016	17,564
Gross profit	6,404	7,756	6,710	7,059	27,929
Research & development	3,237	4,522	4,632	4,018	16,409
Selling, general & administrative	5,442	4,997	5,554	3,841	19,834
Operating income	(7,045)	(8,478)	(10,244)	(6,332)	(32,099)
Interest expense	1,084	1,382	1,413	1,446	5,325
Pretax income	(7,782)	(9,544)	(11,375)	(7,464)	(36,165)
Income tax	4.0	8.0	(38.0)	(4.0)	(30.0)
Net income	(7,786)	(9,552)	(11,337)	(7,460)	(36,135)
EPS (basic) ($)		(0.32)	(0.38)	(0.24)	(1.21)
EPS (diluted) ($)		(0.32)	(0.38)	(0.24)	(1.21)
Weighted avg. shares (basic)		29,547	30,167	30,983
Weighted avg. shares (diluted)		29,547	30,167	30,983

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 28, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 59 more quarters, back to Mar 2011, with Tormere Pro.

Corporate Events (8-K)

11 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 28, 2026 accepted 4:05 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Aug 3, 2026 accepted 4:05 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
May 21, 2026 accepted 4:30 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 13, 2026 accepted 4:05 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Mar 17, 2026 accepted 4:08 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Feb 5, 2026 accepted 4:25 PM ET	8-K/A 9.01Exhibits	Document SEC ↗
Jan 12, 2026 accepted 8:31 AM ET	2.02Earnings release	Document SEC ↗
Jan 5, 2026 accepted 8:30 AM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Nov 20, 2025 accepted 5:08 PM ET	1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
Nov 6, 2025 accepted 4:57 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

61%

W/W +12.9pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-29	2026-07-01	BURNETT JOSEPH	Director & CEO and President	Sale	20.0K	$19.38	$388K	116.8K	View
2026-06-17	2026-06-22	BURNETT JOSEPH	Director & CEO and President	Sale	61.8K	$17.79	$1.10M	116.8K	View
2026-05-21	2026-05-26	Klein Matthew B.	Director	Sale	16.0K	$11.59	$185K	46.9K	View
2026-05-20	2026-05-21	FALLON LYNNETTE C	Director	Sale	5,091	$11.14	$57K	48.2K	View
2026-02-25	2026-02-26	BURNETT JOSEPH	Director & CEO and President	Sale	20.0K	$15.17	$303K	193.2K	View

1–5 of 11

1 / 3

Recent News

A 1.71M-share fund position is part of a broader ownership tally at ClearPoint Neuro (CLPT).

Stock Titan · 2026-11-03

ClearPoint Neuro, Inc. Q3 2026 Earnings Call Summary

Yahoo · 2026-10-29

Stifel Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

Benzinga · 2026-10-29

ClearPoint Neuro (CLPT) Q3 2026 Earnings Call Transcript

Yahoo · 2026-10-29

What ClearPoint Neuro (CLPT) Said on Its Q3 Earnings Call

Yahoo · 2026-10-29

ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates

Yahoo · 2026-10-28

ClearPoint Neuro (NASDAQ:CLPT) Falls 25% as Q3 Revenue Miss Overshadows EPS Beat

ChartMill · 2026-10-28

ClearPoint Neuro, Inc. (CLPT) Q3 2026 Earnings Call Transcript

SeekingAlpha · 2026-10-28

ClearPoint Neuro Reports Third Quarter 2026 Results

Yahoo · 2026-10-28

ClearPoint Neuro Q3 2026 Earnings Call Transcript

Benzinga · 2026-10-28

ClearPoint Neuro Narrows FY2026 Sales Guidance from $48.000M-$52.000M to $48.000M-$50.000M vs $49.000M Est

Benzinga · 2026-10-28

ClearPoint Neuro Q3 EPS $(0.24) Beats $(0.32) Estimate, Sales $12.075M Miss $12.300M Estimate

Benzinga · 2026-10-28

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

Yahoo · 2026-10-26

ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026

Yahoo Finance · 2026-10-14

Understanding Momentum Shifts in (CLPT)

Stock Traders Daily · 2026-10-04

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-06-29	BURNETT JOSEPH	S	20,000	$387,600
2026-06-17	BURNETT JOSEPH	S	1,843	$33,063.42
2026-06-17	BURNETT JOSEPH	S	60,000	$1M
2026-05-21	Klein Matthew B.	S	16,000	$185,440
2026-05-20	FALLON LYNNETTE C	S	5,091	$56,713.74

CLPT

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

ClearPoint Neuro, Inc. (CLPT)

Reporting Insiders

Factor Profile

Corporate Events (8-K)